The Pharma Data

DECEMBER 23, 2020

All 38 subjects who were evaluable for immunogenicity had balanced cellular and humoral immune responses following the second dose of INO-4800. Only 6 related Grade 1 adverse events in 5 subjects were observed, primarily mild injection site reactions (e.g., ClinicalTrials.gov identifier: NCT04336410.

DNA 40

DNA Vaccination Vaccine Immune Response 40

Bioengineer

JULY 15, 2021

But some patients develop resistance to current immunotherapies and others have cancers characterized by immunologically “cold” tumors, which evade or suppress the patient’s immune response against his or her cancer. Additional authors on this research are Peter Carlson, Joseph Grudinski, Ph.D., ” ###.

Medicine 52

Medicine Clinical Trials Clinical Trials Scientist 52

XTalks

SEPTEMBER 14, 2020

These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer. China’s COVID-19 Vaccine: Sinovac Biotech and CanSino Biologics. Drugs and Vaccines.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92